Cédric M Hysek1, Gregor Domes, Matthias E Liechti. 1. Division of Clinical Pharmacology and Toxicology, Department of Biomedicine University Hospital and University of Basel, Basel, Switzerland.
Abstract
RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) increases sociability. The prosocial effects of MDMA may result from the release of the "social hormone" oxytocin and associated alterations in the processing of socioemotional stimuli. MATERIALS AND METHODS: We investigated the effects of MDMA (125 mg) on the ability to infer the mental states of others from social cues of the eye region in the Reading the Mind in the Eyes Test. The study included 48 healthy volunteers (24 men, 24 women) and used a double-blind, placebo-controlled, within-subjects design. A choice reaction time test was used to exclude impairments in psychomotor function. We also measured circulating oxytocin and cortisol levels and subjective drug effects. RESULTS:MDMA differentially affected mind reading depending on the emotional valence of the stimuli. MDMA enhanced the accuracy of mental state decoding for positive stimuli (e.g., friendly), impaired mind reading for negative stimuli (e.g., hostile), and had no effect on mind reading for neutral stimuli (e.g., reflective). MDMA did not affect psychomotor performance, increased circulating oxytocin and cortisol levels, and produced subjective prosocial effects, including feelings of being more open, talkative, and closer to others. CONCLUSIONS: The shift in the ability to correctly read socioemotional information toward stimuli associated with positive emotional valence, together with the prosocial feelings elicited by MDMA, may enhance social approach behavior and sociability when MDMA is used recreationally and facilitate therapeutic relationships in MDMA-assisted psychotherapeutic settings.
RCT Entities:
RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) increases sociability. The prosocial effects of MDMA may result from the release of the "social hormone" oxytocin and associated alterations in the processing of socioemotional stimuli. MATERIALS AND METHODS: We investigated the effects of MDMA (125 mg) on the ability to infer the mental states of others from social cues of the eye region in the Reading the Mind in the Eyes Test. The study included 48 healthy volunteers (24 men, 24 women) and used a double-blind, placebo-controlled, within-subjects design. A choice reaction time test was used to exclude impairments in psychomotor function. We also measured circulating oxytocin and cortisol levels and subjective drug effects. RESULTS:MDMA differentially affected mind reading depending on the emotional valence of the stimuli. MDMA enhanced the accuracy of mental state decoding for positive stimuli (e.g., friendly), impaired mind reading for negative stimuli (e.g., hostile), and had no effect on mind reading for neutral stimuli (e.g., reflective). MDMA did not affect psychomotor performance, increased circulating oxytocin and cortisol levels, and produced subjective prosocial effects, including feelings of being more open, talkative, and closer to others. CONCLUSIONS: The shift in the ability to correctly read socioemotional information toward stimuli associated with positive emotional valence, together with the prosocial feelings elicited by MDMA, may enhance social approach behavior and sociability when MDMA is used recreationally and facilitate therapeutic relationships in MDMA-assisted psychotherapeutic settings.
Authors: G J H Dumont; F C G J Sweep; R van der Steen; R Hermsen; A R T Donders; D J Touw; J M A van Gerven; J K Buitelaar; R J Verkes Journal: Soc Neurosci Date: 2009 Impact factor: 2.083
Authors: Kim Wolff; E M Tsapakis; A R Winstock; D Hartley; D Holt; M L Forsling; Katherine J Aitchison Journal: J Psychopharmacol Date: 2006-05 Impact factor: 4.153
Authors: Lars Schulze; Alexander Lischke; Jonas Greif; Sabine C Herpertz; Markus Heinrichs; Gregor Domes Journal: Psychoneuroendocrinology Date: 2011-04-07 Impact factor: 4.905
Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382
Authors: Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin Journal: J Psychopharmacol Date: 2010-07-19 Impact factor: 4.153
Authors: Matthew G Kirkpatrick; Royce Lee; Margaret C Wardle; Suma Jacob; Harriet de Wit Journal: Neuropsychopharmacology Date: 2014-01-22 Impact factor: 7.853
Authors: Patrick C Dolder; Petra Strajhar; Patrick Vizeli; Alex Odermatt; Matthias E Liechti Journal: Psychopharmacology (Berl) Date: 2018-02-09 Impact factor: 4.530
Authors: Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti Journal: Soc Cogn Affect Neurosci Date: 2013-10-04 Impact factor: 3.436